The Changing Pattern of Bacterial and Fungal Respiratory Isolates in Patients with and Without COVID-19 Admitted to Intensive Care Unit

Overview

Journal BMC Infect Dis

Publisher Biomed Central

Specialty Infectious Diseases

Date 2022 Feb 24

PMID 35196993

Authors

Gianluca Zuglian

Diego Ripamonti

Alessandra Tebaldi

Marina Cuntro

Ivano Riva

Claudio Farina

Marco Rizzi

Affiliations

Soon will be listed here.

Abstract

Objectives: Severe acute respiratory syndrome 2 (SARS-CoV-2) pandemic has had a heavy impact on national health system, especially in the first wave. That impact hit principally the intensive care units (ICUs). The large number of patients requiring hospitalization in ICUs lead to a complete upheaval of intensive wards. The increase in bed, the fewer number of nurses per patient, the constant use of personal protective equipment, the new antimicrobial surveillance protocols could have had deeply effects on microbiological flora of these wards. Moreover, the overconsumption of antimicrobial therapy in COVID-19 patients, like several studies report, could have impact of this aspect. Aim of this study is to evaluate the changing pattern of microbiological respiratory isolates during and before COVID-19 pandemic in a tertiary hospital ICUs.

Methods: A retrospective, observational study was conducted in ICUs of "ASST Papa Giovanni XXIII", a large tertiary referral hospital in Northern Italy. We have retrospectively collected the microbiological data from bronchoalveolar lavage (BAL) and tracheal aspirate (TA) of patients with COVID-19, hospitalized in ICUs from 22nd February 2020 to 31st May 2020 (Period 1), and without COVID-19, from 22nd February 2019 to 31st May 2019 (Period 2). We compared the prevalence and the antibiotic profile of bacterial and fungal species in the two time periods.

Results: The prevalence of Pseudomonas spp. shows a statistically significant increase from patients without COVID-19 compared to COVID-19 positive as well as the prevalence of Enterococcus spp. On the contrary, the prevalence of Gram negative non fermenting bacteria (GN-NFB), Haemophilus influenzae and Streptococcus pneumoniae showed a significant reduction between two periods. There was a statistically significant increase in resistance of Pseudomonas spp. to carbapenems and piperacillin/tazobactam and Enterobacterales spp. for piperacillin/tazobactam, in COVID-19 positive patients compared to patients without COVID-19. We did not observe significant changing in fungal respiratory isolates.

Conclusions: A changing pattern in prevalence and resistance profiles of bacterial and fungal species was observed during COVID-19 pandemic.

Citing Articles

Impact of the COVID-19 pandemic on prevalence of highly resistant microorganisms in hospitalised patients in the Netherlands, March 2020 to August 2022.

Altorf-van der Kuil W, Wielders C, Zwittink R, De Greeff S, Dongelmans D, Kuijper E Euro Surveill. 2023; 28(50).

PMID: 38099348 PMC: 10831414. DOI: 10.2807/1560-7917.ES.2023.28.50.2300152.

ICU-Acquired Colonization and Infection Related to Multidrug-Resistant Bacteria in COVID-19 Patients: A Narrative Review.

Gaudet A, Kreitmann L, Nseir S Antibiotics (Basel). 2023; 12(9).

PMID: 37760760 PMC: 10525572. DOI: 10.3390/antibiotics12091464.

Risk Factors Associated with the Development of Hospital-Acquired Infections in Hospitalized Patients with Severe COVID-19.

Solis-Huerta F, Martinez-Guerra B, Roman-Montes C, Tamez-Torres K, Rajme-Lopez S, Ortiz-Conchi N Antibiotics (Basel). 2023; 12(7).

PMID: 37508204 PMC: 10376785. DOI: 10.3390/antibiotics12071108.

Incidence and risk factors for clinically confirmed secondary bacterial infections in patients hospitalized for coronavirus disease 2019 (COVID-19).

Park H, McCracken C, Lininger N, Varley C, Sikka M, Evans C Infect Control Hosp Epidemiol. 2023; 44(10):1650-1656.

PMID: 37184033 PMC: 10587378. DOI: 10.1017/ice.2023.27.

References

Li Y, Meng Q, Rao X, Wang B, Zhang X, Dong F . Corticosteroid therapy in critically ill patients with COVID-19: a multicenter, retrospective study. Crit Care. 2020; 24(1):698. PMC: 7747001. DOI: 10.1186/s13054-020-03429-w. View

Langford B, So M, Raybardhan S, Leung V, Soucy J, Westwood D . Antibiotic prescribing in patients with COVID-19: rapid review and meta-analysis. Clin Microbiol Infect. 2021; 27(4):520-531. PMC: 7785281. DOI: 10.1016/j.cmi.2020.12.018. View

Grau S, Echeverria-Esnal D, Gomez-Zorrilla S, Navarrete-Rouco M, Masclans J, Espona M . Evolution of Antimicrobial Consumption During the First Wave of COVID-19 Pandemic. Antibiotics (Basel). 2021; 10(2). PMC: 7911440. DOI: 10.3390/antibiotics10020132. View

Trentini F, Marziano V, Guzzetta G, Tirani M, Cereda D, Poletti P . Pressure on the Health-Care System and Intensive Care Utilization During the COVID-19 Outbreak in the Lombardy Region of Italy: A Retrospective Observational Study in 43,538 Hospitalized Patients. Am J Epidemiol. 2021; 191(1):137-146. PMC: 8549288. DOI: 10.1093/aje/kwab252. View

Kolar M, Urbanek K, Latal T . Antibiotic selective pressure and development of bacterial resistance. Int J Antimicrob Agents. 2001; 17(5):357-63. DOI: 10.1016/s0924-8579(01)00317-x. View

Damonti L, Kronenberg A, Marschall J, Jent P, Sommerstein R, de Kraker M . The effect of the COVID-19 pandemic on the epidemiology of positive blood cultures in Swiss intensive care units: a nationwide surveillance study. Crit Care. 2021; 25(1):403. PMC: 8607066. DOI: 10.1186/s13054-021-03814-z. View

Enne V, Personne Y, Grgic L, Gant V, Zumla A . Aetiology of hospital-acquired pneumonia and trends in antimicrobial resistance. Curr Opin Pulm Med. 2014; 20(3):252-8. DOI: 10.1097/MCP.0000000000000042. View

Giacobbe D, Battaglini D, Enrile E, Dentone C, Vena A, Robba C . Incidence and Prognosis of Ventilator-Associated Pneumonia in Critically Ill Patients with COVID-19: A Multicenter Study. J Clin Med. 2021; 10(4). PMC: 7913191. DOI: 10.3390/jcm10040555. View

Adler H, Ball R, Fisher M, Mortimer K, Vardhan M . Low rate of bacterial co-infection in patients with COVID-19. Lancet Microbe. 2020; 1(2):e62. PMC: 7279742. DOI: 10.1016/S2666-5247(20)30036-7. View

10.

Perico N, Fagiuoli S, Di Marco F, Laghi A, Cosentini R, Rizzi M . Bergamo and Covid-19: How the Dark Can Turn to Light. Front Med (Lausanne). 2021; 8:609440. PMC: 7933506. DOI: 10.3389/fmed.2021.609440. View

11.

Rees E, Nightingale E, Jafari Y, Waterlow N, Clifford S, Pearson C . COVID-19 length of hospital stay: a systematic review and data synthesis. BMC Med. 2020; 18(1):270. PMC: 7467845. DOI: 10.1186/s12916-020-01726-3. View

12.

Nguyen N, Chinn J, Nahmias J, Yuen S, Kirby K, Hohmann S . Outcomes and Mortality Among Adults Hospitalized With COVID-19 at US Medical Centers. JAMA Netw Open. 2021; 4(3):e210417. PMC: 8547263. DOI: 10.1001/jamanetworkopen.2021.0417. View

13.

Oster Y, Michael-Gayego A, Rivkin M, Levinson L, Wolf D, Nir-Paz R . Decreased prevalence rate of respiratory pathogens in hospitalized patients during the COVID-19 pandemic: possible role for public health containment measures?. Clin Microbiol Infect. 2020; . PMC: 7833997. DOI: 10.1016/j.cmi.2020.12.007. View

14.

Magiorakos A, Srinivasan A, Carey R, Carmeli Y, Falagas M, Giske C . Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect. 2011; 18(3):268-81. DOI: 10.1111/j.1469-0691.2011.03570.x. View

15.

Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y . Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020; 395(10223):497-506. PMC: 7159299. DOI: 10.1016/S0140-6736(20)30183-5. View

16.

Malacarne P, Rossi C, Bertolini G . Antibiotic usage in intensive care units: a pharmaco-epidemiological multicentre study. J Antimicrob Chemother. 2004; 54(1):221-4. DOI: 10.1093/jac/dkh299. View

17.

Rouze A, Martin-Loeches I, Povoa P, Makris D, Artigas A, Bouchereau M . Relationship between SARS-CoV-2 infection and the incidence of ventilator-associated lower respiratory tract infections: a European multicenter cohort study. Intensive Care Med. 2021; 47(2):188-198. PMC: 7778569. DOI: 10.1007/s00134-020-06323-9. View

18.

Robba C, Battaglini D, Pelosi P, Rocco P . Multiple organ dysfunction in SARS-CoV-2: MODS-CoV-2. Expert Rev Respir Med. 2020; 14(9):865-868. PMC: 7441756. DOI: 10.1080/17476348.2020.1778470. View

19.

Fernandez-Barat L, Ferrer M, De Rosa F, Gabarrus A, Esperatti M, Terraneo S . Intensive care unit-acquired pneumonia due to Pseudomonas aeruginosa with and without multidrug resistance. J Infect. 2016; 74(2):142-152. DOI: 10.1016/j.jinf.2016.11.008. View